Navigation Links
SenesTech, Inc. Appoints Susan Airhart to Board of Directors
Date:2/12/2009

FLAGSTAFF, Ariz., Feb. 12 /PRNewswire/ -- SenesTech, Inc. announced a vibrant new addition today to their dynamic Board of Directors. Susan Airhart of Bar Harbor, Maine, was unanimously elected by the Board to fill a vacancy and is the newest member.

Airhart is a successful biotechnology professional with 20 years of experience in the life science industry. She possesses a multitude of career accomplishments that include establishing and launching successful business plans, lab management for a bi-coastal national lab, generation of year over year revenue growth in both emerging and mature markets, out- and in-licensing technologies to build revenue and product development management. She is currently Senior Director of Strategic Opportunities and Product Management for The Jackson Laboratory in Bar Harbor, Maine. Prior to joining Jackson she was director of Business Development for Oncor, Inc., a molecular diagnostics and research reagents biotechnology company. Airhart joins the current Board consisting of Everett Hale, also Chief Executive Officer; Dr. Loretta Mayer, Chairman of the Board and also Chief Scientific Officer; Dr. Cheryl Dyer, also President; Roger Bollard, also Chief Financial Officer, and Dr. Timothy Vail, also Vice President of Manufacturing & Regulation.

SenesTech's first product, ContraPest(TM), will dramatically improve rice yields in Southeast Asia by reducing the rice field rat population. Over half of the worlds 6 billion people rely on rice as a primary food source and Southeast Asia produces over 84% of this resource. Today, 1/5-1/3 of the Southeast Asian rice crop is damaged by these rodents. The company's product is a unique non-toxic, environmentally sound product that can dramatically reduce the rice rat population resulting in a significant reduction in the devastation caused by this pest in just one growing season. A mere 10% increase in rice production will feed an additional 380 million people.

Airhart's addition to the Board of Directors will support SenesTech's plans to launch their products in the first quarter of 2010. She will serve as a Director along with the current Board until the next regularly scheduled annual meeting of shareholders.

For additional information contact Everett Hale @ ehale@senestech.com or visit www.senestech.com

About: (SenesTech, Inc.) SenesTech is a platform technology company located in Flagstaff, Arizona, on the Northern Arizona Center for Emerging Technology campus. SenesTech specializes in environmentally neutral population management products for companion animals and wildlife.


'/>"/>
SOURCE SenesTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SenesTech, Inc. Commences Product Registration Process With Australian Government
2. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
3. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
4. Agendia Appoints VP of Business Development
5. Informed Medical Communications Appoints New Vice President, Information Technology
6. 3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
7. Aerovance Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer
8. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
9. January 2009 - Rahu Appoints David Greensmith to Non Executive Directo
10. EUCODIS Bioscience Appoints Thomas Fischer as Chief Financial Officer
11. Amylin Pharmaceuticals Appoints Vincent Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, announced ... the company as Chief Financial Officer (CFO), effective ... with 20 years of experience in financial management ... biotech and software companies. Most recently, Ms. Bovenizer ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet ... to discuss the benefits of a viscoelastic disc. AxioMed received CE mark in ...
Breaking Biology Technology:
(Date:11/30/2016)... SAN FRANCISCO and WARSAW, Poland , Nov. 30, 2016 ... sleeping. It is one of the most crucial aspects of recovery so we need ... host of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and ... family and friends sleep and find a Christmas present that could help them to ... ...
(Date:11/29/2016)... Lithuania , Nov. 29, 2016 /PRNewswire/ ... biometric identification and object recognition technologies, today ... (SDK) for fingerprint recognition solutions that run ... a fingerprint template using less than 128KB ... in compact devices that have limited on-board ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):